CURADEV THERAPEUTICS UP PRIVATE LIMITED
Noida, Uttar Pradesh
In their own words
Curadev Therapeutics UP Private Limited, a recently incorporated translational startup, has the rights to develop Curadev Pharma’s novel anti-cancer First-in-Class drug candidate CRD3874-SI, which is a classical small molecule allosteric STING activator, that was conceptualized, discovered, synthesized and developed on Indian soil in Noida, Uttar Pradesh with the aim of launching the first indigenously developed anti-cancer drug from India for regulated markets worldwide.
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- DPIIT recognition number
- DIPP228618
- CIN
- U72100UP2025PTC232799
- Registered on Startup India
- 2025
- Self-declared stage
- Validation
Where this is
District
Noida
Uttar Pradesh
Startup India records the district. We do not have a street address for this company, and we will not invent one.
No point is drawn, because we do not have one.
Geocode confidence: medium
What we do not know
- no incorporation date
- no funding signal of any kind
- no address beyond the district
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, write to trust@indianstartupmap.com.